©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2006; 12(21): 3338-3343
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3338
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3338
Table 1 Baseline characteristics of the group of children with chronic hepatitis B
| Data of the patients | Mean | SD | Minimum | Maximum |
| Age (yr) | 8 | 3.51 | 4 | 16 |
| HBV infection (mo) | 44 | 30 | 10 | 144 |
| ALT (nkat/L) | 1600 | 1567 | 350 | 9902 |
| AST (nkat/L) | 1367 | 1117 | 567 | 7718 |
| GGT (nkat/L) | 250 | 150 | 50 | 1150 |
| Bilirubin (μmol/L) | 8.5 | 4.3 | 3.4 | 23.9 |
| Albumin (g/L) | 65.6 | 4.2 | 57.2 | 74.3 |
| Hyaluronan (μg/L) | 34.3 | 21.5 | 14.6 | 113.5 |
| Tenascin (μg/L) | 748.8 | 265.9 | 295.6 | 1480.2 |
| TIMP-1(μg/L) | 558.1 | 121.2 | 342.2 | 852.3 |
| Collagen VI (μg/L) | 5.8 | 2.2 | 2.3 | 14.2 |
| Staging | 2.0 | 0.6 | 1 | 3 |
| Grading | 1.6 | 0.7 | 1 | 3 |
- Citation: Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12(21): 3338-3343
- URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3338.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i21.3338